OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis
Nian Liu, Mingjie Yan, Qian Tao, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 9, pp. e007146-e007146
Open Access | Times Cited: 23

Showing 23 citing articles:

The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Jie Wu, Nian Liu, Jing Chen, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 10

Single-atom–doped piezocatalyst induces copper-free cuproptosis in tumor therapy
M. Zhang, Xinran Song, Yu Qin, et al.
Science Advances (2025) Vol. 11, Iss. 7
Open Access | Times Cited: 1

Decoding mitochondria's role in immunity and cancer therapy
Yu Shrike Zhang, Hong Yan, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189107-189107
Open Access | Times Cited: 6

Targeting metabolic pathways to counter cancer immunotherapy resistance
Yuki Agarwala, Timothy Brauns, Ann E. Sluder, et al.
Trends in Immunology (2024) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 6

DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway
Sichen Di, Wenjin Chen, Wei Yang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 6

Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
Dongjie Chen, Pengyi Liu, Xiongxiong Lu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5

The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities
Marco Cordani, Federica Michetti, Ali Zarrabi, et al.
Neoplasia (2024) Vol. 58, pp. 101076-101076
Closed Access | Times Cited: 4

A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment
Aoling Huang, Hao Xue, Ting Xie, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

PLUNC downregulates the expression of PD-L1 by inhibiting the interaction of DDX17/β-catenin in nasopharyngeal carcinoma
Ran-Ran Feng, Yilin Guo, Meilin Chen, et al.
Journal of Pathology and Translational Medicine (2025) Vol. 59, Iss. 1, pp. 68-83
Open Access

Global trends and emerging insights in BRAF and MEK inhibitor resistance in melanoma: a bibliometric analysis
Jianhao Bai, Zhongqi Wan, Wanru Zhou, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access

PLOD1 promotes the malignancy of hepatocellular carcinoma by facilitating NF-κB/IL-6/STAT3-dependent TCA cycle
Chengfei Zhang, Yangchun Zhou, Minghua Hu, et al.
JHEP Reports (2025) Vol. 7, Iss. 5, pp. 101329-101329
Open Access

Fasting enhances the efficacy of Sorafenib in breast cancer via mitophagy mediated ROS-driven p53 pathway
Ru Li, Yimei Ma, Anqi He, et al.
Free Radical Biology and Medicine (2025)
Closed Access

Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+T-cell antitumor activity via the non-canonical P53/STING pathway
Jie Wu, Nian Liu, Jing Chen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010252-e010252
Open Access

The landscape of ATF3 in tumors: metabolism, expression regulation, therapy approach, and open concerns
Xu Zhao, Chao Chen, Hui Qiu, et al.
Pharmacological Research (2025), pp. 107666-107666
Open Access

Metabolism of Tryptophan, Glutamine, and Asparagine in Cancer Immunotherapy—Synergism or Mechanism of Resistance?
Kajetan Kiełbowski, Estera Bakinowska, Rafał Becht, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 144-144
Open Access

Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma
Nian Liu, Mingjie Yan, Can Lü, et al.
Biomaterials (2024) Vol. 314, pp. 122815-122815
Closed Access | Times Cited: 3

Maternal Undernutrition Affects Fetal Thymus DNA Methylation, Gene Expression, and, Thereby, Metabolism and Immunopoiesis in Wagyu (Japanese Black) Cattle
Ouanh Phomvisith, Susumu Muroya, Konosuke OTOMARU, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9242-9242
Open Access | Times Cited: 1

The function and mechanism of clinical trial agent CPI-613 in multiple myeloma
Haiqin Wang, Yibin Zhang, Yufeng Jiang, et al.
Biochemical Pharmacology (2024) Vol. 232, pp. 116717-116717
Closed Access | Times Cited: 1

Effects of Combined Exposure to 17α-Methyltestosterone and Polystyrene Microplastics on Lipid Metabolism and the Nervous System in Danio rerio
Tongyao Li, Gen Chen, Lu Cao, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 247, pp. 106665-106665
Closed Access

Page 1

Scroll to top